Literature DB >> 22149583

Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques.

Frank Tacke1, Ralf Weiskirchen.   

Abstract

Hepatic stellate cells (HSCs), also called Ito cells or lipocytes, are vitamin A-storing cells located in the Dissé space between hepatocytes and sinusoidal endothelial cells. Upon liver injury, these cells transdifferentiate into extracellular matrix-producing, highly proliferative myofibroblasts that promote hepatic fibrogenesis. Other possible collagen-producing cells in liver fibrosis include portal fibroblasts, bone marrow-derived cells (mesenchymal stem cells, fibrocytes and hematopoietic cells) and parenchymal cells undergoing epithelial-to-mesenchymal transition. Important factors and signaling pathways for HSC activation, as well as different functions of HSC during homeostasis and fibrosis, such as collagen production, secretion of cytokines and chemokines, immune modulation and changes in contractile features, as well as vitamin A storage capacity, have been identified in vitro and in vivo. Novel isolation techniques, specifically HSC sorting by FACS via autofluorescence and antibodies, will provide us with further opportunities to advance our understanding of HSC biology in health and disease.

Entities:  

Mesh:

Year:  2012        PMID: 22149583     DOI: 10.1586/egh.11.92

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  66 in total

1.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

2.  Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells.

Authors:  Kyu Min Kim; Chang Yeob Han; Ji Young Kim; Sam Seok Cho; Yun Seok Kim; Ja Hyun Koo; Jung Min Lee; Sung Chul Lim; Keon Wook Kang; Jae-Sung Kim; Se Jin Hwang; Sung Hwan Ki; Sang Geon Kim
Journal:  J Hepatol       Date:  2018-01-02       Impact factor: 25.083

Review 3.  Genetically modified mouse models to study hepatic neutral lipid mobilization.

Authors:  Guenter Haemmerle; Achim Lass
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-05       Impact factor: 5.187

4.  Human parenchymal and non-parenchymal liver cell isolation, culture and characterization.

Authors:  Georg Damm; Elisa Pfeiffer; Britta Burkhardt; Jan Vermehren; Andreas K Nüssler; Thomas S Weiss
Journal:  Hepatol Int       Date:  2013-10-10       Impact factor: 6.047

Review 5.  Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.

Authors:  Matthias Bartneck; Klaudia Theresa Warzecha; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 6.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 7.  Cytoglobin in tumor hypoxia: novel insights into cancer suppression.

Authors:  Sankalpa Chakraborty; Rince John; Alo Nag
Journal:  Tumour Biol       Date:  2014-05-10

8.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

9.  Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.

Authors:  Silke Leiting; Sebastian Seidl; Adoracion Martinez-Palacian; Lars Muhl; Sandip M Kanse
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

Review 10.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.